Home › Funds › DAFNA Capital Management LLC › LRMR
DAFNA Capital Management LLC position in LRMR
Larimar Therapeutics Inc · Health Care
DAFNA Capital Management LLC reported holding 2,008,164 shares of LRMR (Larimar Therapeutics Inc) in its Q2 2026 13F filing — a position valued at US$6.1M, representing 1.17% of its reported portfolio and ranking #21 among its reported holdings. DAFNA Capital Management LLC has disclosed LRMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DAFNA Capital Management LLC's LRMR position evolved
DAFNA Capital Management LLC first disclosed a stake in LRMR in Q3 2023 at 327,373 shares (US$1.3M). The position peaked in Q1 2026 at 2,029,164 shares, worth US$9.1M. Across 12 filings, DAFNA Capital Management LLC increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,008,164 shares valued at US$6.1M — a reduction of -21,000 shares quarter over quarter.. Notable position changes include a 103% increase in Q1 2024 (shares fell 4% over the following quarter), a 177% increase in Q3 2025 (shares rose 18% over the following quarter), a 116% increase in Q1 2026 (shares fell 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 327.37K | $1.29M | New |
| Q4 2023 | 323.87K | $1.47M | Reduce |
| Q1 2024 | 656.37K | $4.98M | Add |
| Q2 2024 | 639.97K | $4.64M | Reduce |
| Q3 2024 | 494.27K | $3.24M | Reduce |
| Q4 2024 | 371.43K | $1.44M | Reduce |
| Q1 2025 | 371.43K | $798.58K | Hold |
| Q2 2025 | 371.43K | $1.07M | Hold |
| Q3 2025 | 1.03M | $3.32M | Add |
| Q4 2025 | 939.16K | $3.58M | Reduce |
| Q1 2026 | 2.03M | $9.13M | Add |
| Q2 2026 | 2.01M | $6.12M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LRMR and 13F data
LRMR (Larimar Therapeutics Inc) is a Health Care company. 25 other funds we track also report a position in LRMR — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$108.6M), Defilade Capital Management, L.P. (US$11.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LRMR
- DEERFIELD MANAGEMENT COMPANY, L.P. 35.61M sh · $108.60M · Q2 2026
- Defilade Capital Management, L.P. 3.67M sh · $11.19M · Q2 2026
More on DAFNA Capital Management LLC
FAQ
How long has DAFNA Capital Management LLC held LRMR?
DAFNA Capital Management LLC has disclosed LRMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is DAFNA Capital Management LLC's current position in LRMR?
As of Q2 2026, DAFNA Capital Management LLC holds 2.01M shares of LRMR (Larimar Therapeutics Inc), valued at $6.12M, representing 1.17% of its reported portfolio and ranking #21.
Has DAFNA Capital Management LLC been buying or selling LRMR?
In the latest 13F filing (Q2 2026), DAFNA Capital Management LLC reduced its position in LRMR. The position peaked in Q1 2026 at 2.03M shares.
Which other funds hold LRMR?
Other major institutional holders of LRMR include DEERFIELD MANAGEMENT COMPANY, L.P., Defilade Capital Management, L.P., among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.